Tango Therapeutics, Inc. (TNGX) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $62.38M | +48.3% |
| 2024 | $42.07M | +15.2% |
| 2023 | $36.53M | +46.9% |
| 2022 | $24.86M | -32.9% |
| 2021 | $37.04M | +383.8% |
| 2020 | $7.66M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $62.38M | +48.3% |
| 2024 | $42.07M | +15.2% |
| 2023 | $36.53M | +46.9% |
| 2022 | $24.86M | -32.9% |
| 2021 | $37.04M | +383.8% |
| 2020 | $7.66M | — |